FT. LAUDERDALE, FL) – February 6, 2026 – Trividia Health, Inc., announced today that it is initiating a labeling correction which requires a modification of the Owner’s Booklets/System Instructions for Use for all TRUE METRIX, TRUE METRIX AIR, TRUE METRIX GO, and TRUE METRIX PRO Blood Glucose Monit
Similar Posts
Ongoing | Cancer Accelerated Approvals
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications that have postmarketing requirement(s) for ongoing clinical trial(s) to verify clinical benefit.Activities Report of the Generic Drug Program | FDARA Title VIII Sections 807 and 805
Section 807 of the FDA Reauthorization Act of 2017 (FDARA) requires the FDA to report on certain abbreviated new drug applications (ANDAs).Concord Biotech Limited – 04/28/2025-05/02/2025
Concord Biotech Limited – 04/28/2025-05/02/2025. Country: India. Record Type: 483Timeline of Selected FDA Activities and Significant Events Addressing Substance Use and Overdose Prevention
Timeline of Selected FDA Activities and Significant Events Addressing Opioid Misuse and AbuseBlendHouse Portland LLC. Portland, OR. EIR issued 04/26/2024
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 04/26/2024
Short Title (70 char) BlendHouse Portland LLC. Portland, OR. EIR issued 04/26/2024
FEI Number 3013670080
Firm Name BlendHouse Portland LLC
Record Type EIR
State OR
Establishment Type ManufacturerDrugs@FDA Data Files
Drugs@FDA Downloadable Data File in ZIP format, Data Definitions, and Entity Relationship Diagram (ERD)